Computational identification of drug-like marine natural products as potential RNA polymerase inhibitors against Nipah virus

被引:8
|
作者
Abduljalil, Jameel M. [1 ]
Elfiky, Abdo A. [2 ]
Sayed, El-Sayed T. A. [3 ]
AlKhazindar, Maha M. [3 ]
机构
[1] Thamar Univ, Fac Appl Sci, Dept Biol Sci, Dhamar, Yemen
[2] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt
[3] Cairo Univ, Fac Sci, Dept Bot & Microbiol, Giza 12613, Egypt
关键词
Henipavirus; Molecular modeling; Mononegavirales; Natural products; Paramyxoviridae; RdRp; MOLECULAR-DYNAMICS; PROTEIN DYNAMICS; FORCE-FIELD; FUNGUS; SIMULATIONS;
D O I
10.1016/j.compbiolchem.2023.107850
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nipah virus (NiV) has been an alarming threat to human populations in southern Asia for more than a decade. It is one of the most deadly viruses in the Mononegavirales order. Despite its high mortality rate and virulence, no chemotherapeutic agent or vaccine is publicly available. Hence, this work was conducted to computationally screen marine natural products database for drug-like potential inhibitors for the viral RNA-dependent RNA polymerase (RdRp). The structural model was subjected to molecular dynamics (MD) simulation to obtain the native ensemble of the protein. The CMNPDB dataset of marine natural products was filtered to retain only compounds following Lipinski's five rules. The molecules were energy minimized and docked into different conformers of the RdRp using AutoDock Vina. The best 35 molecules were rescored by GNINA, a deep learning -based docking software. The resulting nine compounds were evaluated for their pharmacokinetic profiles and medicinal chemistry properties. The best five compounds were subjected to MD simulation for 100 ns, followed by binding free energy estimation via Molecular Mechanics/ Generalized Born Surface Area (MM/GBSA) cal-culations. The results showed remarkable behavior of five hits as inferred by stable binding pose and orientation to block the exit channel of RNA synthesis products in the RdRp cavity. These hits are promising starting ma-terials for in vitro validation and structural modifications to enhance the pharmacokinetic and medicinal chemistry properties for developing antiviral lead compounds.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Identification and Evaluation of Natural Compounds as Potential Inhibitors of NS2B-NS3 Zika Virus Protease: A Computational Approach
    Anede, Nada
    Ouassaf, Mebarka
    Rengasamy, Kannan R. R.
    Khan, Shafi Ullah
    Alhatlani, Bader Y.
    MOLECULAR BIOTECHNOLOGY, 2024,
  • [42] Identification of Novel PBP2B Protein Inhibitors against Streptococcus pneumoniae in Marine Natural Products using an In-Silico Approach
    Chandrasekar, Karthickeyan
    Subbiah, Parthasarathy
    CURRENT PROTEOMICS, 2024,
  • [43] Identification of natural compounds as potential antiviral drug candidates against Hepatitis E virus through molecular docking and dynamics simulations
    Uddin, Mohammad Borhan
    Praseetha, P. K.
    Ahmed, Rony
    Shaheen, Mir Md
    Kaouche, Farah Chafika
    Bairagi, Rahul Dev
    Jawi, Motasim
    Alharbi, Hanan M.
    Khojah, Alaa A.
    Hassan, Hesham M.
    Al-Emam, Ahmed
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2024, 101 (12)
  • [44] Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach
    Elkaeed, Eslam B.
    Alsfouk, Bshra A.
    Ibrahim, Tuqa H.
    Arafa, Reem K.
    Elkady, Hazem
    Ibrahim, Ibrahim M.
    Eissa, Ibrahim H.
    Metwaly, Ahmed M.
    ANTIVIRAL THERAPY, 2023, 28 (05)
  • [45] Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
    Stephen Ejeh
    Adamu Uzairu
    Gideon A. Shallangwa
    Stephen E. Abechi
    Future Journal of Pharmaceutical Sciences, 7
  • [46] Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictions
    Ejeh, Stephen
    Uzairu, Adamu
    Shallangwa, Gideon A.
    Abechi, Stephen E.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [47] Identification of Potential SARS-CoV-2 Inhibitors: A selected Natural Compounds Targeting RNA-dependent-RNA Polymerase Activity, and Binding Affinity of the Receptor-binding Domain (RBD)
    Altayb, Hisham N.
    Chaieb, Kamel
    Bouslama, Lamjed
    Abdulhakim, Jawaher A.
    Baothman, Othman A. S.
    Aloqail, Mai M.
    Alfadhel, Munerah
    Zamzami, Mazin A.
    Elsayid, Mohieldin
    Moglad, Ehssan H.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (03): : 701 - 718
  • [48] Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
    Molavi, Zahra
    Razi, Sara
    Mirmotalebisohi, Seyed Amir
    Adibi, Amirjafar
    Sameni, Marzieh
    Karami, Farshid
    Niazi, Vahid
    Niknam, Zahra
    Aliashrafi, Morteza
    Taheri, Mohammad
    Ghafouri-Fard, Soudeh
    Jeibouei, Shabnam
    Mahdian, Soodeh
    Zali, Hakimeh
    Ranjbar, Mohammad Mehdi
    Yazdani, Mohsen
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [49] Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitors
    Afolabi, Rufus
    Chinedu, Shalom
    Ajamma, Yvonne
    Adam, Yagoub
    Koenig, Rainer
    Adebiyi, Ezekiel
    INFECTION GENETICS AND EVOLUTION, 2022, 97
  • [50] Virtual screening of natural products as potential inhibitors of SARS-CoV-2 main protease, RNA-dependent RNA polymerase (RdRp) and Spike Protein: Database design, molecular docking and molecular dynamic study
    Boozari, Motahareh
    Tehranizadeh, Zeinab Amiri
    Hosseinzadeh, Hossein
    AVICENNA JOURNAL OF PHYTOMEDICINE, 2024, 14 (05) : 600 - 616